fda update on tirzepatide F.D.A. Approves New Obesity Drug That Will Compete With Wegovy Compounders protest as FDA removes

By reducing excess body fat and improving metabolic function, clinical trials show these medications frequently help patients lower high cholesterol and improve overall cardiovascular markers

Mississippi Releases Guidance on IVs and Semaglutide By Patrick OBrien, General Counsel, American Med Spa Association (AmSpa) The Mississippi State Board of Medical Licensure recently released two guidance documents

These findings indicate that semaglutide (Ozempic) provides greater improvements in both HbA1c and weight compared to liraglutide

Lastly, therapeutic interventions targeting the liver-brain axis remain in the early stages, necessitating rigorous clinical trials to establish efficacy and safety